These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25174923)

  • 21. Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics.
    Merzoug A; Chikhi A; Bensegueni A; Boucherit H; Okay S
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
    J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms.
    Fieulaine S; Juillan-Binard C; Serero A; Dardel F; Giglione C; Meinnel T; Ferrer JL
    J Biol Chem; 2005 Dec; 280(51):42315-24. PubMed ID: 16192279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slow-binding inhibition of peptide deformylase by cyclic peptidomimetics as revealed by a new spectrophotometric assay.
    Nguyen KT; Hu X; Pei D
    Bioorg Chem; 2004 Jun; 32(3):178-91. PubMed ID: 15110195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide deformylase inhibitors as potent antimycobacterial agents.
    Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
    Howard MH; Cenizal T; Gutteridge S; Hanna WS; Tao Y; Totrov M; Wittenbach VA; Zheng YJ
    J Med Chem; 2004 Dec; 47(27):6669-72. PubMed ID: 15615515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and Inhibits Bacterial Growth: An
    Singh AK; Prajapati KS; Kumar S
    Curr Pharm Des; 2022; 28(35):2890-2900. PubMed ID: 36154601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
    Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
    J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
    Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
    Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment.
    Lv F; Chen C; Tang Y; Wei J; Zhu T; Hu W
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3714-8. PubMed ID: 27293070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
    Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
    Boularot A; Giglione C; Artaud I; Meinnel T
    Curr Opin Investig Drugs; 2004 Aug; 5(8):809-22. PubMed ID: 15600237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study.
    Khan FA; Patil RH; Patil M; Arote R; Shinde DB; Sangshetti JN
    Arch Pharm (Weinheim); 2016 Dec; 349(12):934-943. PubMed ID: 27859538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-terminal residue of phage Vp16 PDF, the smallest peptide deformylase, acts as an offset element locking the active conformation.
    Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Bienvenut WV; Dian C; Meinnel T; Giglione C
    Sci Rep; 2017 Sep; 7(1):11041. PubMed ID: 28887476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
    Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
    Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward More Selective Antibiotic Inhibitors: A Structural View of the Complexed Binding Pocket of
    Kirschner H; Heister N; Zouatom M; Zhou T; Hofmann E; Scherkenbeck J; Stoll R
    J Med Chem; 2024 Apr; 67(8):6384-6396. PubMed ID: 38574272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.